Senores Pharmaceuticals Ltd. NSE: SENORES | BSE: 544319

Strong Performer, Getting Expensive

776.75 -9.75 (-1.24%)

231.1K

NSE+BSE Volume

NSE 05 Dec, 2025 3:31 PM (IST)

Regulatory Approval

Senores secures Philippines FDA nod to market 10 drugs, with a market size of Rs 191 crore See details

Board Meetings - Senores Pharmaceuticals

The latest board meeting for Senores Pharmaceuticals took place on 06 Nov 2025, for the purpose of Quarterly Results

Ex-date	Purpose	Notes
06 Nov 2025	Quarterly Results	-
23 Jul 2025	Quarterly Results & Others	To consider other business matters.
15 May 2025	Audited Results	-
23 Jan 2025	Quarterly Results & Others	To consider other business matters.